1.12 -0.05 (-4.27%)

76.57% Fall from 52W High

275.4K XNAS Volume

XNAS 21 Mar, 2025 2:29 PM (EDT)



Insider Trading disclosures for Tevogen Bio Holdings Inc.

The latest disclosure was made by Neal Flomenberg in Tevogen Bio Holdings Inc. where a trade of 232,968 Common Stock done at an average price of $1.1 was reported to US exchanges on March 12, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.09 per share. 12 Mar 2025 232,968 3,595,608 - 1.1 253,935 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.05 per share. 07 Mar 2025 70,252 3,828,576 - 1.1 73,765 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.09 per share. 07 Mar 2025 70,384 3,898,828 - 1.1 76,719 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.14 per share. 07 Mar 2025 71,273 3,969,212 - 1.1 81,251 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.10 per share. 04 Mar 2025 88,519 4,040,485 - 1.1 97,371 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.21 per share. 04 Mar 2025 110,659 4,129,004 - 1.2 133,897 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.28 per share. 04 Mar 2025 14,639 4,239,663 - 1.3 18,738 Common Stock
Patton Curtis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 240,000 1,209,618 - 0 Common Stock
Susan M. Podlogar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 240,000 433,923 - 0 Common Stock
Feike Jeffrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 240,000 821,771 - 0 Common Stock
Victor Sordillo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 240,000 336,962 - 0 Common Stock
Keow Lin Goh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 240,000 433,923 - 0 Common Stock
Sordillo Victor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2024 240,000 576,962 - 0 Common Stock
Neal Flomenberg See Remarks Sale of securities on an exchange or to another person at price $ 1.62 per share. 17 Oct 2024 1,078,600 4,254,302 - 1.6 1,747,332 Common Stock
Kirti Desai Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.82 per share. 12 Jun 2024 3,000 9,699,186 - 0.8 2,460 Common Stock
Ryan Saadi Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.77 per share. 05 Jun 2024 2,607 118,252,659 - 0.8 2,000 Common Stock
Kirti Desai Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 9,696,186 9,696,186 - - Common Stock
Victor Sordillo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 96,962 96,962 - - Common Stock
Curtis Patton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 969,618 969,618 - - Common Stock
Keow Lin Goh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 193,923 193,923 - - Common Stock
Jeffrey Feike Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 581,771 581,771 - - Common Stock
Sadiq Khan Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 969,618 969,618 - - Common Stock
Neal Flomenberg Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 5,332,902 5,332,902 - - Common Stock
Ryan Saadi Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 98,901,098 98,901,098 - - Common Stock
Ryan Saadi Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 19,348,954 118,250,052 - 0 Common Stock
Ryan Saadi Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 193,923 193,923 - - Common Stock
Susan M. Podlogar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 193,923 193,923 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures